123 related articles for article (PubMed ID: 8439495)
1. Characterisation of a humanised bispecific monoclonal antibody for cancer therapy.
Bruynck A; Seemann G; Bosslet K
Br J Cancer; 1993 Mar; 67(3):436-40. PubMed ID: 8439495
[TBL] [Abstract][Full Text] [Related]
2. Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptide.
Karacay H; McBride WJ; Griffiths GL; Sharkey RM; Barbet J; Hansen HJ; Goldenberg DM
Bioconjug Chem; 2000; 11(6):842-54. PubMed ID: 11087333
[TBL] [Abstract][Full Text] [Related]
3. Humanisation and characterisation of PR1A3, a monoclonal antibody specific for cell-bound carcinoembryonic antigen.
Stewart LM; Young S; Watson G; Mather SJ; Bates PA; Band HA; Wilkinson RW; Ross EL; Snary D
Cancer Immunol Immunother; 1999 Feb; 47(6):299-306. PubMed ID: 10203059
[TBL] [Abstract][Full Text] [Related]
4. Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.
Kraeber-Bodéré F; Faibre-Chauvet A; Saï-Maurel C; Gautherot E; Fiche M; Campion L; Le Boterff J; Barbet J; Chatal JF; Thédrez P
J Nucl Med; 1999 Jan; 40(1):198-204. PubMed ID: 9935077
[TBL] [Abstract][Full Text] [Related]
5. Generation of bispecific monoclonal antibodies for two phase radioimmunotherapy.
Bosslet K; Steinstraesser A; Hermentin P; Kuhlmann L; Bruynck A; Magerstaedt M; Seemann G; Schwarz A; Sedlacek HH
Br J Cancer; 1991 May; 63(5):681-6. PubMed ID: 2039692
[TBL] [Abstract][Full Text] [Related]
6. Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen.
Arakawa F; Haruno M; Kuroki M; Kanda H; Watanabe T; Misumi Y; Matsuoka Y
Hybridoma; 1993 Aug; 12(4):365-79. PubMed ID: 8244416
[TBL] [Abstract][Full Text] [Related]
7. Enhanced binding activity observed between anti-carcinoembryonic monoclonal antibodies.
Wellerson R; Kaplan P
Hybridoma; 1986; 5(3):199-213. PubMed ID: 2429910
[TBL] [Abstract][Full Text] [Related]
8. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
[TBL] [Abstract][Full Text] [Related]
9. Induction of an immune response through the idiotypic network with monoclonal anti-idiotype antibodies in the carcinoembryonic antigen system.
de Moraes JZ; Carneiro CR; Buchegger F; Mach JP; Lopes JD
J Cell Biochem; 1992 Nov; 50(3):324-35. PubMed ID: 1281819
[TBL] [Abstract][Full Text] [Related]
10. Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans.
Sharkey RM; Goldenberg DM; Goldenberg H; Lee RE; Ballance C; Pawlyk D; Varga D; Hansen HJ
Cancer Res; 1990 May; 50(9):2823-31. PubMed ID: 2328505
[TBL] [Abstract][Full Text] [Related]
11. Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.
Beidler CB; Ludwig JR; Cardenas J; Phelps J; Papworth CG; Melcher E; Sierzega M; Myers LJ; Unger BW; Fisher M
J Immunol; 1988 Dec; 141(11):4053-60. PubMed ID: 3141512
[TBL] [Abstract][Full Text] [Related]
12. A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently.
Wang XB; Zhao BF; Zhao Q; Piao JH; Liu J; Lin Q; Huang HL
J Biochem; 2004 Apr; 135(4):555-65. PubMed ID: 15115782
[TBL] [Abstract][Full Text] [Related]
13. Anti-chelate antibodies after intraperitoneal yttrium-90-labeled monoclonal antibody immunoconjugates for ovarian cancer therapy.
Kosmas C; Maraveyas A; Gooden CS; Snook D; Epenetos AA
J Nucl Med; 1995 May; 36(5):746-53. PubMed ID: 7738643
[TBL] [Abstract][Full Text] [Related]
14. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.
Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C
Year Immunol; 1993; 7():96-105. PubMed ID: 8372516
[No Abstract] [Full Text] [Related]
15. Efficient bispecific monoclonal antibody purification using gradient thiophilic affinity chromatography.
Kreutz FT; Wishart DS; Suresh MR
J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):161-70. PubMed ID: 9766856
[TBL] [Abstract][Full Text] [Related]
16. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
Karacay H; Sharkey RM; Govindan SV; McBride WJ; Goldenberg DM; Hansen HJ; Griffiths GL
Bioconjug Chem; 1997; 8(4):585-94. PubMed ID: 9258459
[TBL] [Abstract][Full Text] [Related]
17. The analysis of internal image-bearing anti-idiotypic monoclonal antibody in relation to carcinoembryonic antigen.
Tsujisaki M; Hinoda Y; Tokuchi S; Hanzawa Y; Arimura Y; Masuya J; Kitagawa H; Okochi E; Shimamura T; Hamuro J
J Immunol; 1993 Jan; 150(2):508-16. PubMed ID: 8419483
[TBL] [Abstract][Full Text] [Related]
18. Cloning and sequencing of variable region cDNAs of a novel human monoclonal antibody to carcinoembryonic antigen, and generation of a single chain variable fragmented antibody.
Shibaguchi H; Kuroki M; Kuroki M; Badran A; Hachimine K; Kinugasa T
Anticancer Res; 2004; 24(5C):3355-60. PubMed ID: 15515431
[TBL] [Abstract][Full Text] [Related]
19. [Optimization of methods for immobilizing antibodies against the carcino-embryonic antigen on insoluble matrices. Equilibrium parameters of the interaction of the immobilized antibodies with the antigen].
Guzov VM; Usanov SA
Biokhimiia; 1988 Nov; 53(11):1772-82. PubMed ID: 3075142
[TBL] [Abstract][Full Text] [Related]
20. Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen.
Bhattacharya-Chatterjee M; Mukerjee S; Biddle W; Foon KA; Köhler H
J Immunol; 1990 Oct; 145(8):2758-65. PubMed ID: 1698862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
